Curative Biotechnology, Inc. (CUBT)

Curative Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.02	0.06	0.06	0.67	0.16
Cash & Short-Term Investments	0.02	0.06	0.06	0.67	0.16
Cash Growth	-65.36%	-3.87%	-91.25%	317.33%	-
Other Receivables	-	0.12	-	0.03	-
Receivables	-	0.12	-	0.03	-
Prepaid Expenses	0.19	0.43	-	0.06	1.9
Other Current Assets	-	-	-	-	0.07
Total Current Assets	0.21	0.6	0.06	0.75	2.13
Property, Plant & Equipment	0	0.01	0.01	0.01	0
Other Intangible Assets	1.35	1.42	1.51	1.56	0.14
Long-Term Deferred Charges	0.6	0.57	0.49	0.09	-
Total Assets	2.16	2.6	2.06	2.41	2.27
Accounts Payable	4.08	3.49	3.43	0.73	0.1
Short-Term Debt	0.26	2.26	1.12	-	0.56
Current Portion of Long-Term Debt	2.73	-	-	-	-
Other Current Liabilities	-	-	0.04	0	0.01
Total Current Liabilities	7.08	5.75	4.6	0.73	0.66
Total Liabilities	7.08	5.75	4.6	0.73	0.66
Common Stock	0.09	0.09	0.06	0	0
Additional Paid-In Capital	36.88	34.99	29.81	10.56	3.58
Retained Earnings	-41.89	-38.23	-32.41	-26.92	-8.1
Total Common Equity	-4.92	-3.15	-2.54	-16.36	-4.52
Shareholders' Equity	-4.91	-3.14	-2.54	1.68	1.61
Total Liabilities & Equity	2.16	2.6	2.06	2.41	2.27
Total Debt	2.99	2.26	1.12	-	0.56
Net Cash (Debt)	-2.97	-2.2	-1.07	0.67	-0.4
Net Cash Per Share	-0.00	-0.00	-0.00	0.00	-0.00
Filing Date Shares Outstanding	919.26	903.26	572.01	571.65	544.79
Total Common Shares Outstanding	919.26	903.26	572.01	570.65	333
Working Capital	-6.86	-5.14	-4.54	0.02	1.47
Book Value Per Share	-0.01	-0.00	-0.00	-0.03	-0.01
Tangible Book Value	-6.26	-4.57	-4.05	-17.92	-4.66
Tangible Book Value Per Share	-0.01	-0.01	-0.01	-0.03	-0.01

Updated Nov 30, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.